drugset / Trial / NCT00623363

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

NCT00623363 ↗

Phase 2 Completed 27 enrolled Daiichi Sankyo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to obtain preliminary information on the effect of piclozotan on motor complications associated with Parkinson's Disease.

Timeline

Start
2007-07-13
Primary completion
2008-07-17
Completion
2008-07-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator piclozotan Small molecule — Intravenous

Indications